Table 2 Patient demographics, current users of T therapy
N = 407 | |
|---|---|
Menopausal status, N (percent) | |
Premenopausal | 43 (10.6%) |
Postmenopausal | 364 (89.4%) |
Age, mean (SD), (range) | |
1st insert | 51.7 + 8.1 y (27.4–80.0) |
Current | 61.1 + 8.4 y (37.9–91.7) |
Weight, mean (SD) | |
1st insert | 69.6 + 15.1 kg |
Current | 69.8 + 13.6 kg |
Length of T therapy, mean (SD) | 9.34 + 1.71 y |
Current T dose, mean (SD) | 192 + 50 mg |
Aromatase inhibitor use, N (percent) | |
Total | 86 (21.1%) |
Premenopausal | 27 (62.8%) |
Postmenopausal | 59 (16.2%) |